Brands: Naropin · Ropivacaine Hydrochloride
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi USA, LLC | unknown | 32 | SUPPLYING |
| Anthea Pharma Private Limited | unknown | 9 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 8 | SUPPLYING |
| Eugia US LLC | unknown | 7 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | unknown | 7 | SUPPLYING |
| Sagent Pharmaceuticals | unknown | 6 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 3 | SUPPLYING |
| Baxter Healthcare Corporation | unknown | 2 | SUPPLYING |
| Gland Pharma Limited | unknown | 2 | SUPPLYING |
| Mylan Institutional LLC | unknown | 2 | SUPPLYING |
| SOLA Pharmaceuticals, LLC | unknown | 2 | SUPPLYING |
| Sportpharm LLC | unknown | 2 | SUPPLYING |
| Henry Schein, Inc. | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Ropivacaine Hydrochloride Injection — reported in shortage by InfoRLife SA. Therapeutic category: Anesthesia.
Ropivacaine Hydrochloride Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anesthesia.
Ropivacaine Hydrochloride Injection — reported in shortage by Eugia US LLC. Therapeutic category: Anesthesia.
Pill